Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Different volatility measures reveal different risk facets of stock indices. This primer clarifies what each metric means for decisions.
23,218 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Senate rebukes Trump-era spending as GOP dissent grows, delaying a roughly $70 billion budget package and stirring ma...
SpaceX has secured a $2 billion Space Force contract to develop and sustain satellites. The award strengthens ties be...
Dan Ives of Wedbush argues the AI revolution is still in its early innings, signaling multi-year upside for Nvidia an...
Former Google CEO Eric Schmidt highlights a tension between competitiveness and work-life balance as U.S. firms face ...
MicroStrategy offloads 32 BTC to cover dividend payouts on its perpetual preferred shares, signaling a shift from a p...
As enterprise cybersecurity budgets surge toward $215B by 2026, three ETFs stand out by delivering broad, full-stack ...
A former Republican congressman receives a presidential pardon from Trump, erasing insider-trading gains tied to a ma...
Rising capex threatens the cash-flow yields that power popular cash cows. This report explains why and what investors...
Pre-IPO momentum for SpaceX is building after AI-focused contracts surface, potentially lifting annual revenue run ra...
Many investors chase flashy AI stories, but the real upside often sits in quiet, essential software that scales AI ac...
Arm jumps on AI-driven data-center royalties, while Qualcomm climbs on automotive and data-center strength. The chip-...